Elacestrant Impresses in EMERALD Trial of Breast Cancer
![](https://www.generalsurgerynews.com/aimages/2022/GSN0122_009a_13251_425.jpg)
![](https://images.ctfassets.net/tgf4i61m32yj/WjbTH2VpW7Tt8VInwzJLt/0399e84b98bd01fc28f5bb54b815609e/SABCS-Roundtable-3000x2000.jpg)
Experts Discuss Clinical Highlights from SABCS 2021
![](https://www.generalsurgerynews.com/aimages/2022/GSN0122_009a_13251_425.jpg)
Elacestrant Impresses in EMERALD Trial of Breast Cancer
![](https://slideplayer.com/slide/12942429/78/images/21/Meta-analysis+of+Adjuvant+Trastuzumab+in+HER2%2B+Breast+Cancer.jpg)
May 30 - June 3, 2014 Chicago, Illinois - ppt download
![](https://image.slidesharecdn.com/breastlandmark-170112195611/85/landmark-trials-in-breast-cancer-80-320.jpg?cb=1710959291)
LANDMARK TRIALS IN BREAST CANCER
![](https://cf-images.us-east-1.prod.boltdns.net/v1/jit/10203567001/6d650791-e54c-4790-90fc-17f6f6e2ad14/main/1280x720/1m3s146ms/match/image.jpg)
EMERALD Trial: Elacestrant for ER+/HER2- Metastatic Breast Cancer
![](https://pbs.twimg.com/media/FngnawGX0AA7ETm.jpg:large)
Oncology Brothers on X: 3. #EMERALD trial for #Elacestrant HR+ mESR1 advanced breast CA -median PFS was 3.8 month - Common AE: musculoskeletal pain, nausea, increased cholesterol #bcsm
![](https://www.dovepress.com/getfile_article_fulltext.php?filename=article_fulltext%2Fs400000%2F400563/img/OTT_A_400563_t0002.jpg)
Elacestrant in management of ER-Positive, HER2-Negative BC
J.P. Morgan 2022 Conference Review, PDF, Novartis
![](https://image.slidesharecdn.com/breastlandmarktrialsdr-191114173125/85/breast-landmark-trials-drkiran-40-320.jpg?cb=1707391601)
Breast landmark trials dr.kiran